Cancer: Rectal Cancer Rectal
Conditions
Interventions
A randomised trial designed to test the null hypothesis 'whether the Belly Board will improve the reproducibility of the patient's position and reduce the amount of small bowel within the radiation fi
Sponsors
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: 50 patients who have histopathologically confirmed, resectable Rectal Adenocarcinoma who will be undergoing pelvic radiotherapy. Inclusion criteria are: 1. Histopathology confirmed, resectable rectal adenocarcinoma 2. No prior pelvic radiotherapy 3. Staging CT Chest Abdomen and Pelvis excludes metastases 4. MRI staging T3/4 or N1 or T2 lower third rectal tumours 5. Age > 18 6. KPS > 70 and independently mobile to get onto the belly board 7. No contraindications to 5FU chemotherapy 8. Informed consent obtained 9. Subject able to fit into CT scanner on belly board
Exclusion criteria
Exclusion criteria: Not meeting any of the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The reproducibility of the patients position in our standard prone set up compared with that using the Belly Board 2. The small bowel volume within the radiation fields in our standard prone set up compared with that using the Belly Board | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the patient comfort and ease of set up using our standard prone set up compared with that using the Belly Board 2. To compare the acute toxicity of radiotherapy delivered using our standard prone set up with that using the Belly Board | — |
Countries
United Kingdom
Outcome results
None listed